<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35321473</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Respiratory Outcomes After 6 Months of Hospital Discharge in Patients Affected by COVID-19: A Prospective Cohort.</ArticleTitle><Pagination><StartPage>795074</StartPage><MedlinePgn>795074</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">795074</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.795074</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Considering millions of people affected by Coronavirus disease 2019 (COVID-19), long-lasting sequelae can significantly impact health worldwide. Data from prospective studies in lower-middle-income countries on persistent lung dysfunction secondary to COVID-19 are lacking. This work aims to determine risk factors and the impact of persistent lung dysfunctions in COVID-19 survivors.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Observational and prospective cohort of patients admitted to a tertiary hospital from June 2020 to November 2020. Persistence of chest CT scan alterations, desaturation in the six-minute walk test (6MWT), forced expiratory volume in one second (FEV1), lung carbon monoxide diffusion (DLCO), and maximum inspiratory pressure (MIP) were measured 6 months after hospital discharge. Additionally, the Barthel index (BI) and the Modified Medical Research Council (mMRC) Dyspnea Scale were used to determine the impact of lung dysfunction in activities of daily living (ADL).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">It was included 44 patients. Sixty percent had persistent lung CT scan abnormalities. From 18 to 43% of patients had at least one pulmonary function dysfunction, a decrease in FEV1 was the least prevalent (18%), and a reduction in DLCO and MIP was the most frequent (43%). In general, female gender, comorbidity index, and age were associated with worse lung function. Additionally, the presence of lung dysfunction could predict worse BI (r-square 0.28) and mMRC (r-square 0.32).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Long-term lung dysfunction is relatively common in survivors from severe COVID-19 and impacts negatively on ADL and the intensity of dyspnea, similar to studies in high-income countries.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Prestes, Simon, Walz, Ritter and Dal-Pizzol.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prestes</LastName><ForeName>Gabriele da Silveira</ForeName><Initials>GDS</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Biomedicine, Graduate Program in Health Sciences, Universidade do Extremo Sul Catarinense, Criciuma, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Carla Sasso</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, Universidade do Extremo Sul Catarinense, Crici&#xfa;ma, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walz</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Center for Applied Neuroscience (CeNAp), University Hospital - UFSC, Federal University of Santa Catarina, Florian&#xf3;polis, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritter</LastName><ForeName>Cristiane</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, Universidade do Extremo Sul Catarinense, Crici&#xfa;ma, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital S&#xe3;o Jos&#xe9;, Crici&#xfa;ma, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dal-Pizzol</LastName><ForeName>Felipe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, Universidade do Extremo Sul Catarinense, Crici&#xfa;ma, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center, Hospital S&#xe3;o Jos&#xe9;, Crici&#xfa;ma, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">activities of daily living</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">mMRC scale</Keyword><Keyword MajorTopicYN="N">post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">pulmonary function</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>24</Day><Hour>5</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35321473</ArticleId><ArticleId IdType="pmc">PMC8936421</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.795074</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ranzani OT, Bastos LS, Gelli JG, Marchesi JF, Bai&#xe3;o F, Hamacher S, et al. . Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of Nationwide data. Lancet Respir Med. (2021) 9:407&#x2013;18. 10.1016/S2213-2600(20)30560-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30560-9</ArticleId><ArticleId IdType="pmc">PMC7834889</ArticleId><ArticleId IdType="pubmed">33460571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. (2021) 19:141&#x2013;54. 10.1038/s41579-020-00459-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani C, Kadl A. Surviving COVID-19: a burden yet to come? Chest. (2021) 160:15&#x2013;6. 10.1016/j.chest.2021.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.04.019</ArticleId><ArticleId IdType="pmc">PMC8261022</ArticleId><ArticleId IdType="pubmed">34246363</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. (2020) 324:782&#x2013;93. 10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>McGroder CF, Zhang D, Choudhury MA, Salvatore MM, D'Souza BM, Hoffman EA, et al. . Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length. Thorax. (2021) 76:1242&#x2013;5. 10.1136/thoraxjnl-2021-217031</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217031</ArticleId><ArticleId IdType="pmc">PMC8103561</ArticleId><ArticleId IdType="pubmed">33927016</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald LT. Cure after COVID-19: survivors are at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. (2021) 320:257&#x2013;65. 10.1152/ajplung.00238.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00238.2020</ArticleId><ArticleId IdType="pmc">PMC7900916</ArticleId><ArticleId IdType="pubmed">33355522</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. . 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. (2021) 9:747&#x2013;54. 10.1016/S2213-2600(21)00174-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. . 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. (2021) 398:747&#x2013;58. 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Barichello T, Sayana P, Giridharan VV, Arumanayagam AS, Narendran B, Della Giustina A, et al. . Long-term cognitive outcomes after sepsis: a translational systematic review. Mol Neurobiol. (2019) 56:186&#x2013;251. 10.1007/s12035-018-1048-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1048-2</ArticleId><ArticleId IdType="pubmed">29687346</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizarro-Pennarolli C, S&#xe1;nchez-Rojas C, Torres-Castro R, Vera-Uribe R, Sanchez-Ramirez DC, Vasconcello-Castillo L, et al. . Assessment of activities of daily living in patients post COVID-19: a systematic review. PeerJ. (2021) 9:e11026. 10.7717/peerj.11026</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.11026</ArticleId><ArticleId IdType="pmc">PMC8034364</ArticleId><ArticleId IdType="pubmed">33868804</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X, Yao L, Tan Y, Shen Z, Zheng H, Zhou H, et al. . Quantitative and semi-quantitative CT assessments of lung lesion burden in COVID-19 pneumonia. Sci Rep. (2021) 11:5148. 10.1038/s41598-021-84561-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84561-7</ArticleId><ArticleId IdType="pmc">PMC7933172</ArticleId><ArticleId IdType="pubmed">33664342</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira MAF, Medeiros GA, Boeno FP, Sanches PRS, da Silva DP Jr, Muller AF. Oxygen desaturation during the six-minute walk test in COPD patients. J Bras Pneumol. (2014) 40:222&#x2013;8. 10.1590/S1806-37132014000300004</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1806-37132014000300004</ArticleId><ArticleId IdType="pmc">PMC4109193</ArticleId><ArticleId IdType="pubmed">25029644</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Maryland State Med J. (1965) 14:56&#x2013;61. 10.1037/t02366-000</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/t02366-000</ArticleId><ArticleId IdType="pubmed">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha J, et al. . Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. (1999) 54:581&#x2013;6. 10.1136/thx.54.7.581</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J, Ben&#xed;tez ID, Carmona P, Santisteve S, Monge A, Moncus&#xed;-Moix A, et al. . CIBERESUCICOVID Project (COV20/00110, ISCIII). Pulmonary function and radiologic features in survivors of critical COVID-9: a 3-month prospective cohort. Chest. (2021) 160:187&#x2013;98. 10.1016/j.chest.2021.02.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.02.062</ArticleId><ArticleId IdType="pmc">PMC7930807</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramirez DC, Normand K, Zhaoyun Y, Torres-Castro R. Long-term impact of COVID-19: a systematic review of the literature and meta-analysis. Biomedicines. (2021) 9:900. 10.3390/biomedicines9080900</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080900</ArticleId><ArticleId IdType="pmc">PMC8389585</ArticleId><ArticleId IdType="pubmed">34440104</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Committee for the COMEBAC Study Group . Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. (2021) 325:1525&#x2013;34. 10.1001/jama.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>